v3.25.2
Segment and Other Information (Tables)
 12 Months Ended
Aug. 28, 2025
Segment Reporting [Abstract]  
Schedule of results by segment
For the year ended 2025
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$13,524 $7,229 $11,859 $4,753 $13 $— $37,378 
Cost of goods sold5,867 3,995 8,650 3,566 14 413 22,505 
Gross margin7,657 3,234 3,209 1,187 (1)(413)14,873 
Research and development1,315 864 836 435 — 348 3,798 
Selling, general, and administrative213 188 390 195 — 219 1,205 
Restructure and asset impairment
— — — — — 39 39 
Other operating (income) expense, net— 2 2 — — 57 61 
Operating income (loss)$6,129 $2,180 $1,981 $557 $(1)$(1,076)$9,770 

For the year ended 2024
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$3,792 $4,984 $11,667 $4,631 $37 $— $25,111 
Cost of goods sold2,677 3,638 10,222 3,598 20 (657)19,498 
Gross margin1,115 1,346 1,445 1,033 17 657 5,613 
Research and development769 960 994 425 — 282 3,430 
Selling, general, and administrative107 139 485 186 (1)213 1,129 
Restructure and asset impairment
— — — — — 1 1 
Other operating (income) expense, net(5)(8)(33)(10)— (195)(251)
Operating income (loss)$244 $255 $(1)$432 $18 $356 $1,304 

For the year ended 2023
CMBUCDBU
MCBU
AEBUAll Other
Unallocated
Total
Revenue$1,872 $2,124 $7,394 $4,139 $11 $— $15,540 
Cost of goods sold1,801 1,967 9,072 2,905 4 1,207 16,956 
Gross margin71 157 (1,678)1,234 7 (1,207)(1,416)
Research and development755 622 1,122 389 — 226 3,114 
Selling, general, and administrative90 104 414 176 (1)137 920 
Restructure and asset impairment
— — — — — 171 171 
Other operating (income) expense, net(6)(6)(25)(11)— 172 124 
Operating income (loss)$(768)$(563)$(3,189)$680 $8 $(1,913)$(5,745)
Schedule of unallocated amounts [reconciliation of operating profit (loss) from segments to consolidated]
The table below presents the unallocated amounts:
For the year ended
202520242023
Unallocated
Cost of goods sold:
Stock-based compensation$409 $312 $201 
Provision to write down inventories to net realizable value
— — 1,831 
Lower costs from sale of inventory written down in prior periods
— (987)(844)
Other
4 18 19 
413 (657)1,207 
Research and development:
Stock-based compensation347 296 226 
Other
1 (14)— 
348 282 226 
Selling, general, and administrative:
Stock-based compensation219213137
Restructure and asset impairment:39 1 171 
Other operating (income) expense, net:
Patent license charges57 — — 
Goodwill impairment
— — 101 
Litigation settlement— — 68 
Patent cross-license agreement gain
— (200)— 
Other— 5 3 
57 (195)172 
Total unallocated amounts
$1,076 $(356)$1,913 
Schedule of depreciation and amortization expense by segment
Depreciation and amortization expense included in operating income (loss) was as follows:
For the year ended
202520242023
CMBU$2,260 $1,112 $909 
CDBU1,530 1,434 1,020 
MCBU3,177 3,762 4,319 
AEBU1,375 1,447 1,486 
All Other5 7 3 
Unallocated5 18 19 
$8,352 $7,780 $7,756